Synthetic Biology
Support and Educational Content

“Boomerang”—targeting cancer treatments to cancer cells

Ben-Gurion University iGEM team targets cancer with CRISPR

Coopting CRISPR-Cas9 tools for targeting

CRISPR-Cas9 tools are revolutionizing genome editing, but the easy genomic targeting of Cas9 also has great potential for non-editing applications. It is now common to read about use of recombinant dCas9 variants with inactivated nuclease activity. By conjugating dCas9 to other proteins, it is possible to create Cas9 transcription activators, repressors, or fluorescent tags that can be used to target sequences throughout the genome for purposes other than gene modification [1]. The Ben-Gurion University (BGU) iGEM overgrad team used a variant of dCas9 conjugated with a VP64 transcription activator, derived from herpes simplex virus, to develop a cancer targeting system.

2015 was the third year that BGU participated in the International Genomic Engineering Machine (iGEM) competition. In two previous iGEM competitions, the BGU teams were mentored by Prof Smadar Cohen. This year Prof Cohen recruited Dr Efrat Forti and Dr Emil Ruvinov from her lab to assemble and advise the 2015 BGU team. In addition to these 2 advisors, the team was composed of 8 students from different departments, including MD-PhD student Shoham Rigbi. Dr Ruvinov, Dr Forti, and Shoham Rigbi talked with us about their Boomerang project.

iGEM Ben Gurion-team

The Boomerang system

The Boomerang project began with an idea from one of the medical students, Ori Zelichov, who was interviewing to join the team. During his medical training, he observed that many cancer treatments are not specific to cancer cells. He suggested the team develop a tool that would distinguish cancer cells, and either kill the cancer cells or express a reporter that could improve other clinical procedures. The team called their project “Boomerang” because it turns phenotypic features that typically promote survival of cancer cells against the same cells for therapeutic purposes.

The team says that their greatest challenge was designing the Boomerang system. After much research and discussion, they settled on 3 core components. The first 2 components would be a dCas9-VP64 recombinant protein and the CRISPR guide RNA necessary to guide that protein to its targets. To ensure that the system would only target cancer cells, the team used promoters for telomerase reverse transcriptase (hTERT) and enhanced survival (human survivin)—characteristically activated only in cancer cells—to activate transcription of the dCas9-VP64 and guide RNA components. This means that their system requires 2 signals to turn itself on, increasing the likelihood that it will only be active in cancer cells.

The third component of the system was left undefined by the team. Instead, they propose that the VP64 activator of their dCas9-VP64 can be used to produce a variety of outcomes, including expression of a reporter system to help doctors see cancer cells, expression of a mechanism to kill the cancer cells, or some other useful mechanism that can be tailored to the clinician’s or researcher’s needs (Figure 1). The project resulted in awards for Best Health and Medicine Project and Overgrad Grand Prize 1st Runner–Up in the 2015 iGEM competition. They were also awarded Best New Basic Part, and were nominated for Best Part Collection.

iGEM Ben Gurion-Fig 1

Figure 1. Possible applications for the Boomerang CRISPR cancer system. The Boomerang system expresses a dCas9-VP64 transcription activator and requisite guide RNA only in cancer cells. Use of the VP64 transactivation domain means that the system can activate a variety of downstream mechanisms as shown.

Free gBlocks® Gene Fragments saved more than money

iGEM teams have access to varying levels of resources, but they typically have very limited budgets. In 2015, IDT offered iGEM teams up to 20 kb of sequence-verified gBlocks Gene Fragments for use in their projects. gBlocks Gene Fragments are double-stranded DNA of up to 2 kb in length that are perfect for gene assembly. The team used gBlocks fragments to synthesize various BioBrick components (functional DNA sequences contained within a plasmid vector that conform to iGEM restriction-enzyme assembly standards for modular assembly) needed for the Boomerang system. The ability to simply order these BioBrick constructs, rather than synthesize them in the lab, saved the team critical time, allowing them to focus on other aspects of their project, including executing their proof-of-concept experiments. The team emphasizes the great experience they had working with the local IDT distributor in Israel, Synthezza Bioscience, which accompanied them from the design to synthesis and cloning processes.

iGEM experience promotes successful young scientists

Most iGEM teams have only 7–8 months at most to work on their projects. They typically spend time during the academic year planning their projects, and scramble to do the lab work over the summer. The competition strongly emphasizes collaboration, both within and between teams, and includes numerous awards for achievements from excellent science and strong collaboration ethic, to best presentation skills, and software and Wiki site design. The competition is also intended to be fun and, even for teams that do not win awards, it provides these young students with excellent real life experience in independent research, collaboration, and presentation.

Considering the short duration and fast pace of the iGEM competition, the rewards beyond the competition can also be quite remarkable. Work on the BGU project has led the team to apply for a patent on their design and, following the competition, the students are discussing how to complete additional experiments to support its application. The team has also been recognized for its achievements beyond iGEM—by Ben-Gurion University and in national television and radio news programs. All of this occurred for these young researchers, most of whom had little to no prior research experience, in less than one year. Similar stories are told by other teams, and this educational aspect of the program underlines the influence of the iGEM competition.

However, perhaps the most important thing about the iGEM competition is the individual accomplishments. Team member Shoham Rigbi, who presented Team Ben Gurion’s project to more than 2700 people, will now return to her normal studies, taking the lessons and encouragement of this amazing experience with her. Dr Forti, now completing her postdoctoral studies, recalls how much she enjoyed this opportunity to mentor the team through this incredible experience. And, as with all remarkable experiences, iGEM is unlikely to be forgotten by anyone who has the opportunity to take part in it.


  1. Perez-Pinera P, Kocak DD, et al. (2013) RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods, 10(10):973–976.


    Product focus

    gBlocks® Gene Fragments are double-stranded, sequence-verified, DNA genomic blocks, 125–2000 bp in length, that can be shipped in 2–5 working days for affordable and easy gene construction or modification. These DNA fragments have been used in a wide range of applications including CRISPR-mediated genome editing, antibody research, codon optimization, mutagenesis, and aptamer expression. They can also be used for generating qPCR standards.

    Learn more about gBlocks Gene Fragments at

    Related reading

    iGEM teams engineer success with gBlocks® Gene Fragments—By August 2015, the 2015 iGEM teams had made significant progress on their projects. We spoke with some of the teams to find out how the competition was going, and how they were using gBlocks Gene Fragments.

    iGEM students engineer biological tools for a better world—Projects from 2 of the prize-winning 2013 iGEM teams show how non-standard natural and synthetic amino acids can be used in 1) peptide synthesis, and 2) tuberculosis monitoring and treatment. Both projects make use of gBlocks® Gene Fragments to speed construct assembly.

    The gene construction revolution—See how use of high-quality, custom dsDNA fragments as a starting material allows you to turn what might otherwise be multi-step cloning assemblies into simpler reactions. You can often just order the entire target sequence ready for cloning or other uses.

    Codon optimization tool makes synthetic genes easy—Use the IDT Codon Optimization Tool to simplify designing synthetic genes and gBlocks® Gene Fragments for expression in a variety of organisms.

    IDT has improved the efficiency of CRISPR-Cas9 genome editing—Webinar summary: Learn how research conducted at IDT led to the development of a potent new set of CRISPR-Cas9 genome editing tools.

    Author: Hans Packer, PhD, is a scientific writer at IDT.

    © 2016 Integrated DNA Technologies. All rights reserved. Trademarks contained herein are the property of Integrated DNA Technologies, Inc. or their respective owners. For specific trademark and licensing information, see

    gBlocks® Gene Fragments

    Double-stranded DNA up to 2,000 kb—great for easy gene construction, CRISPR genome editing, and more.

    Learn how ≫

    Related Articles

    CRISPR and Cas9 for Flexible Genome Editing

    Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) for targeted gene editing or removal of sequences.

    Read more ≫

    Cloning Strategies Part 3: Blunt-End Cloning

    Tips and tricks for blunt-end cloning.

    Read more ≫

    Building Biological Factories for Renewable and Sustainable Products

    Amyris uses genetic engineering and screening technologies to design microorganisms that convert plant-sourced sugars into target molecules, including pharmaceuticals, biofuels, polymers, flavors, and fragrances.

    Read more ≫

    iGEM Students Engineer Biological Tools for a Better World

    iGEM teams show how non-standard natural and synthetic amino acids can be used in 1) peptide synthesis, and 2) disease monitoring and treatment. Both projects make use of gBlocks® Gene Fragments to speed construct assembly.

    Read more ≫

    Creating a Synthetic Immune System for Optimized Immune Profiling

    A high-throughput method for sequencing and quantification of rearranged antigen receptors on T- and B-cells using gBlocks Gene Fragments to create a “gold standard synthetic immune system.”

    Read more ≫